All News
Investing in the Next Generation of Engineering Talent
Integra LifeSciences Reports Second Quarter 2026 Financial Results
Integra LifeSciences reported financial results for the second quarter ending June 30, 2026.
Restoring Lives Through Everyday Impact: The Power of Small Actions
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
Integra LifeSciences announced the appointment of Topaz Kirlew, DBA, MBA, as corporate vice president and chief regulatory officer. Kirlew will lead Integra's global regulatory affairs organization and oversee regulatory strategy, compliance, submissions, and transformation initiatives worldwide.
Integra LifeSciences Announces Key Executive Appointments
Rebuilding Recovery: A Collaborative Approach to Complex Wound Healing
Strengthening Outcomes Together: A Conversation with Two Brothers at Integra LifeSciences
Innovation at Work
Integra LifeSciences Announces Leadership Transition
Stuart M. Essig, chairman of Integra’s Board of Directors, has been appointed president and chief executive officer, effective May 1, 2026. Mr. Essig will continue to serve as chairman. He succeeds Mojdeh Poul who is pursuing other opportunities. Integra also announced that Michael McBreen, currently executive vice president, president, Codman Specialty Surgical, has been appointed chief commercial officer.
Integra LifeSciences Reports First Quarter 2026 Financial Results
Integra LifeSciences reported financial results for the first quarter ending March 31, 2026.
World Health Starts with Innovation
